Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation

Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Our objective in this study was to characterize the efficacy of on-demand dapoxetine (30 and 60 mg) and daily paroxetine (20 mg) usage in treati...

Descripción completa

Detalles Bibliográficos
Autores principales: Simsek, Abdulmuttalip, Kirecci, Sinan Levent, Kucuktopcu, Onur, Ozgor, Faruk, Akbulut, Mehmet Fatih, Sarilar, Omer, Ozkuvanci, Unsal, Gurbuz, Zafer Gokhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215669/
https://www.ncbi.nlm.nih.gov/pubmed/24830690
http://dx.doi.org/10.4103/1008-682X.128467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215669/
https://www.ncbi.nlm.nih.gov/pubmed/24830690
http://dx.doi.org/10.4103/1008-682X.128467

Ejemplares similares